{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:35:17Z","timestamp":1773725717550,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.kint.2020.08.020","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T05:12:13Z","timestamp":1599369133000},"page":"161-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model"],"prefix":"10.1016","volume":"99","author":[{"given":"Paul M.","family":"Schroder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary W.","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Ezekian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janghoon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Manook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Leopardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alton B.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Kwun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Knechtle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.08.020_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"issue":"suppl 1","key":"10.1016\/j.kint.2020.08.020_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 annual data report: kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12659\/AOT.889096","article-title":"Current approaches in national kidney paired donation programs","volume":"18","author":"Mierzejewska","year":"2013","journal-title":"Ann Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trre.2017.01.003","article-title":"Kidney paired exchange and desensitization: strategies to transplant the difficult to match kidney patients with living donors","volume":"31","author":"Pham","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.kint.2020.08.020_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13751","article-title":"Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?","volume":"33","author":"Schinstock","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.08.020_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.08.020_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.08.020_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(16)31595-1","article-title":"Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis","volume":"389","author":"Manook","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2020.08.020_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S1470-2045(17)30578-8","article-title":"Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial","volume":"18","author":"Dimopoulos","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.kint.2020.08.020_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/TP.0000000000001330","article-title":"32 doses of bortezomib for desensitization is not well tolerated and is associated with only modest reductions in anti-HLA antibody","volume":"101","author":"Moreno Gonzales","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2020.08.020_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0b013e3182081333","article-title":"The impact of proteasome inhibition on alloantibody-producing plasma cells in\u00a0vivo","volume":"91","author":"Diwan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2020.08.020_bib13","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2016070727","article-title":"Humoral compensation after bortezomib treatment of allosensitized recipients","volume":"28","author":"Kwun","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.08.020_bib14","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2017010991","article-title":"Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates","volume":"1","author":"Kwun","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.kint.2020.08.020_bib15","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2019030304","article-title":"Pretransplant desensitization with costimulation blockade and proteasome inhibitor reduces DSA and delays antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients","volume":"30","author":"Ezekian","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.08.020_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4049\/jimmunol.170.1.91","article-title":"Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4","volume":"170","author":"Walker","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.08.020_bib17","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1007\/s13277-014-1867-3","article-title":"Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.kint.2020.08.020_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2013.183","article-title":"Targeting co-stimulatory pathways: transplantation and autoimmunity","volume":"10","author":"Ford","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.08.020_bib19","doi-asserted-by":"crossref","first-page":"17ra10","DOI":"10.1126\/scitranslmed.3000116","article-title":"Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation","volume":"2","author":"Poirier","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.kint.2020.08.020_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.12964","article-title":"FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft","volume":"15","author":"Poirier","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib21","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1681\/ASN.2015070774","article-title":"Anti-CD28 antibody and belatacept exert differential effects on mechanisms of renal allograft rejection","volume":"27","author":"Ville","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.08.020_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20130902","article-title":"2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses","volume":"211","author":"Liu","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2020.08.020_bib23","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.4049\/jimmunol.1300470","article-title":"A\u00a0monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety","volume":"191","author":"Suchard","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.08.020_bib24","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/ajt.13688","article-title":"Antibody-mediated rejection in sensitized nonhuman primates: modeling human biology","volume":"16","author":"Burghuber","year":"2016","journal-title":"Am J Transplant"},{"issue":"suppl 4","key":"10.1016\/j.kint.2020.08.020_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ajt.15873","article-title":"Experimental modeling of desensitization: What have we learned about preventing AMR?","volume":"20","author":"Kwun","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/ajt.15067","article-title":"Dual targeting: combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients","volume":"19","author":"Burghuber","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib27","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1097\/TP.0000000000001465","article-title":"Preclinical testing of antihuman CD28 fab' antibody in a novel nonhuman primate small animal rodent model of xenogenic graft-versus-host disease","volume":"100","author":"Hippen","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2020.08.020_bib28","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1172\/JCI98793","article-title":"CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates","volume":"128","author":"Watkins","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2020.08.020_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ajt.14400","article-title":"Selective CD28 blockade results in superior inhibition of donor-specific T follicular helper cell and antibody responses relative to CTLA4-Ig","volume":"18","author":"Badell","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/TP.0b013e3181837626","article-title":"Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels","volume":"86","author":"Issa","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2020.08.020_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/TP.0b013e318183749a","article-title":"Human leukocyte antigen class II antibodies and transplant outcome","volume":"86","author":"Duquesnoy","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2020.08.020_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A\u00a0phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib33","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/j.1600-6143.2012.04184.x","article-title":"CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells","volume":"12","author":"Charbonnier","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1600-6143.2011.03929.x","article-title":"Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/tri.12605","article-title":"Does belatacept improve outcomes for kidney transplant recipients? A systematic review","volume":"28","author":"Talawila","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.kint.2020.08.020_bib36","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/eji.201445190","article-title":"CD28\/CTLA-4\/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity","volume":"45","author":"Vogel","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2020.08.020_bib37","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.1801425","article-title":"Abatacept targets T follicular helper and regulatory T cells, disrupting molecular pathways that regulate their proliferation and maintenance","volume":"202","author":"Glatigny","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.08.020_bib38","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.celrep.2017.01.067","article-title":"T\u00a0regulatory cells support plasma cell populations in the bone marrow","volume":"18","author":"Glatman Zaretsky","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.kint.2020.08.020_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcph.791","article-title":"Pharmacokinetic, pharmacodynamic, and safety profile of a novel anti-CD28 domain antibody antagonist in healthy subjects","volume":"57","author":"Shi","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.kint.2020.08.020_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 meeting report: new concepts in antibody-mediated rejection","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2020.08.020_bib43","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A\u00a02018 reference guide to the Banff Classification of Renal Allograft Pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820310449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820310449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:57:24Z","timestamp":1758761844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820310449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0085253820310449"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.08.020","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}